Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/31/2018
Entire Document
 


In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: June 1, 2018 - June 30, 2018

MOR - 1a

Schedule of Disbursements by Debtor Entity (1)

For the Period: June 1, 2018 - June 30, 2018

(Unaudited)

 

$ USD ‘000s

Debtor        

 

June 1, 2018 - June 30, 2018

   

Cumulative

Since Filing

 

Orexigen Therapeutics, Inc.

  $ 16,288     $ 62,340  
 

 

 

   

 

 

 

Total

  $ 16,288     $ 62,340  

Notes:

 

(1)

The Schedule of Disbursements is presented on a book basis.